- Home
- AKRO vs CUBI Comparison
AKRO vs CUBI Comparison
Compare AKRO & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- CUBI
- Stock Information
- Founded
- AKRO 2017
- CUBI 1994
- Country
- AKRO United States
- CUBI United States
- Employees
- AKRO N/A
- CUBI N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- CUBI Major Banks
- Sector
- AKRO Health Care
- CUBI Finance
- Exchange
- AKRO Nasdaq
- CUBI Nasdaq
- Market Cap
- AKRO 2.8B
- CUBI 1.4B
- IPO Year
- AKRO 2019
- CUBI 2012
- Fundamental
- Price
- AKRO $37.63
- CUBI $45.54
- Analyst Decision
- AKRO Strong Buy
- CUBI Buy
- Analyst Count
- AKRO 9
- CUBI 10
- Target Price
- AKRO $76.29
- CUBI $65.67
- AVG Volume (30 Days)
- AKRO 1.2M
- CUBI 339.5K
- Earning Date
- AKRO 05-09-2025
- CUBI 04-24-2025
- Dividend Yield
- AKRO N/A
- CUBI N/A
- EPS Growth
- AKRO N/A
- CUBI N/A
- EPS
- AKRO N/A
- CUBI 5.09
- Revenue
- AKRO N/A
- CUBI $641,387,000.00
- Revenue This Year
- AKRO N/A
- CUBI $15.13
- Revenue Next Year
- AKRO N/A
- CUBI $9.48
- P/E Ratio
- AKRO N/A
- CUBI $8.95
- Revenue Growth
- AKRO N/A
- CUBI N/A
- 52 Week Low
- AKRO $17.86
- CUBI $40.75
- 52 Week High
- AKRO $58.40
- CUBI $68.49
- Technical
- Relative Strength Index (RSI)
- AKRO 43.61
- CUBI 42.57
- Support Level
- AKRO $36.46
- CUBI $41.86
- Resistance Level
- AKRO $39.13
- CUBI $48.12
- Average True Range (ATR)
- AKRO 3.04
- CUBI 2.66
- MACD
- AKRO 0.06
- CUBI -0.04
- Stochastic Oscillator
- AKRO 57.38
- CUBI 43.62
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About CUBI Customers Bancorp Inc
Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.